148 related articles for article (PubMed ID: 36385235)
1. Availability and affordability of cardiovascular medicines in a major city of Afghanistan in 2020.
Kokabisaghi F; Hashemi-Meshkini A; Obewal A; Ghavami V; Javan-Noughabi J; Shabanikiya H; Varmaghani M; Moghri J
Daru; 2022 Dec; 30(2):343-350. PubMed ID: 36385235
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.
Saeed A; Saeed H; Saleem Z; Fang Y; Babar ZU
PLoS One; 2019; 14(4):e0216122. PubMed ID: 31022276
[TBL] [Abstract][Full Text] [Related]
3. Availability, pricing and affordability of selected medicines for noncommunicable diseases.
Heidari E; Varmaghani M; Abdollahiasl A
East Mediterr Health J; 2019 Oct; 25(7):473-480. PubMed ID: 31612979
[TBL] [Abstract][Full Text] [Related]
4. Availability, price and affordability of essential medicines for managing cardiovascular diseases and diabetes: a statewide survey in Kerala, India.
Satheesh G; Sharma A; Puthean S; Ansil T P M; E J; Raj Mishra S; Unnikrishnan MK
Trop Med Int Health; 2020 Dec; 25(12):1467-1479. PubMed ID: 32959441
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive survey of cancer medicines prices, availability and affordability in Ghana.
Ocran Mattila P; Biritwum RB; Babar ZU
PLoS One; 2023; 18(5):e0279817. PubMed ID: 37134123
[TBL] [Abstract][Full Text] [Related]
6. The Availability, Pricing, and Affordability of Essential Diabetes Medicines in 17 Low-, Middle-, and High-Income Countries.
Babar ZU; Ramzan S; El-Dahiyat F; Tachmazidis I; Adebisi A; Hasan SS
Front Pharmacol; 2019; 10():1375. PubMed ID: 31824316
[No Abstract] [Full Text] [Related]
7. Access to Essential Cardiovascular Medicines in Pakistan: A National Survey on the Availability, Price, and Affordability, Using WHO/HAI Methodology.
Saeed A; Saeed F; Saeed H; Saleem Z; Yang C; Chang J; Jiang M; Zhao M; Saqlain M; Ji W; Aziz MM; Lambojon K; Gillani AH; Hayat K; Gul S; Fang Y; Babar ZU
Front Pharmacol; 2020; 11():595008. PubMed ID: 33708114
[No Abstract] [Full Text] [Related]
8. Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.
Osuafor NG; Ukwe CV; Okonta M
PLoS One; 2021; 16(8):e0255567. PubMed ID: 34383799
[TBL] [Abstract][Full Text] [Related]
9. A national survey on availability, price and affordability of selected essential medicines for non communicable diseases in Sri Lanka.
Dabare PR; Wanigatunge CA; Beneragama BH
BMC Public Health; 2014 Aug; 14():817. PubMed ID: 25103467
[TBL] [Abstract][Full Text] [Related]
10. The Availability and Affordability of Cardiovascular Medicines for Secondary Prevention in Tehran Province (Iran).
Vasheghani Farahani A; Salamzadeh J; Rasekh HR; Najafi S; Mosadegh V
Iran J Pharm Res; 2018; 17(Suppl):64-72. PubMed ID: 29796030
[TBL] [Abstract][Full Text] [Related]
11. Access to essential medicines for diabetes care: availability, price, and affordability in central Ethiopia.
Deressa HD; Abuye H; Adinew A; Ali MK; Kebede T; Habte BM
Glob Health Res Policy; 2024 Apr; 9(1):12. PubMed ID: 38584277
[TBL] [Abstract][Full Text] [Related]
12. Access to Essential Medicines and Diagnostic Tests for Cardiovascular Diseases in Maputo City, Mozambique.
Jessen N; Sharma A; Jones J; Auala T; Boladuadua S; Jingi A; Ferrer J; Mocumbi AO
Glob Heart; 2023; 18(1):8. PubMed ID: 36874443
[TBL] [Abstract][Full Text] [Related]
13. Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon.
Abdel Rida N; Mohamed Ibrahim MI; Babar ZUD
BMC Health Serv Res; 2019 Dec; 19(1):973. PubMed ID: 31852546
[TBL] [Abstract][Full Text] [Related]
14. Prices & availability of common medicines at six sites in India using a standard methodology.
Kotwani A; Ewen M; Dey D; Iyer S; Lakshmi PK; Patel A; Raman K; Singhal GL; Thawani V; Tripathi S; Laing R
Indian J Med Res; 2007 May; 125(5):645-54. PubMed ID: 17642500
[TBL] [Abstract][Full Text] [Related]
15. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
Ewen M; Zweekhorst M; Regeer B; Laing R
PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
[TBL] [Abstract][Full Text] [Related]
16. Availability, price, and affordability of medicines used for the management of Covid-19 in health facilities of Dessie town WHO/HAI survey.
Mohammed SA; Tsehay T; Faris AG; Mengstu G
PLoS One; 2022; 17(12):e0279465. PubMed ID: 36542641
[TBL] [Abstract][Full Text] [Related]
17. Availability, pricing and affordability of essential medicines in Eastern Ethiopia: a comprehensive analysis using WHO/HAI methodology.
Sisay M; Amare F; Hagos B; Edessa D
J Pharm Policy Pract; 2021 Jul; 14(1):57. PubMed ID: 34225781
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Availability, Prices, and Affordability of Selected Essential Medicines in Balochistan, Pakistan.
Bibi M; Haq NU; Kareem A; Ullah H; Baloch N; Rehman G; Nasim A
Int J Public Health; 2022; 67():1604375. PubMed ID: 35872706
[No Abstract] [Full Text] [Related]
19. Assessing the prices and affordability of oncology medicines for three common cancers within the private sector of South Africa.
Mattila PO; Babar ZU; Suleman F
BMC Health Serv Res; 2021 Jul; 21(1):661. PubMed ID: 34229693
[TBL] [Abstract][Full Text] [Related]
20. WHO key access antibiotics price, availability and affordability in private sector pharmacies in Pakistan.
Saleem Z; Saeed H; Akbar Z; Saeed A; Khalid S; Farrukh L; Irfan A; Anam A; Hassali MA; Rasheed H; Babar ZU
Cost Eff Resour Alloc; 2021 Feb; 19(1):10. PubMed ID: 33593366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]